Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Google News
mountsinai.org > about > newsroom > 2026 > two-mount-sinai-researchers-named-inaugural-cumming-global-fellows-for-pandemic-therapeutics-research

Two Mount Sinai Researchers Named Inaugural Cumming Global Fellows for Pandemic Therapeutics Research | Mount Sinai - New York

4+ day, 41+ min ago   (260+ words) Two microbiology researchers at the Icahn School of Medicine at Mount Sinai have been named inaugural Cumming Global Fellows, receiving three-year fellowships to advance antibody therapies against emerging viruses with pandemic potential. Goran Bajic, PhD, and Raianna Fantin, PhD, researchers…...

Mount Sinai Health System
mountsinai.org > about > newsroom > 2026 > mount-sinai-researchers-report-largest-study-supporting-three-courses-of-radiation-for-children-with-deadly-brain-tumor

Mount Sinai Researchers Report Largest Study Supporting Three Courses of Radiation for Children With Deadly Brain Tumor

1+ week, 5+ day ago   (303+ words) The study combines Mount Sinai's institutional experience with every previously published case from around the world, creating the largest reported experience to date of three-course re-irradiation for this rare pediatric brain tumor. The findings suggest that carefully selected patients may…...

Mount Sinai Health System
mountsinai.org > about > newsroom > 2026 > mount-sinai-study-finds-chemotherapy-free-treatment-shows-promise-for-some-patients-with-metastatic-breast-cancer

Mount Sinai Study Finds Chemotherapy-Free Treatment Shows Promise for Some Patients With Metastatic Breast Cancer

3+ week, 4+ day ago   (326+ words) Researchers at the Icahn School of Medicine at Mount Sinai found that a chemotherapy-free combination of four targeted therapies showed encouraging results in patients with HR-positive, HER2-positive metastatic breast cancer, offering a potential first-line treatment option that may be more…...